Push for Personal Medicine Boosts Firm
RND Group Hires Chief Architect
RND Group is selected by Osmetech to design, implement, and test the software for the eSensor® XT-8 Instrument
Join RND at AACC
RND Group President, Tim DeFrench, Answers Questions for Medical Device Link's Consultants Corner
RND Group Reviews Banner Year
RND designs software for life-saving devices
The RND Group Joins Bio IT Alliance
The RND Group’s client, Gen-Probe Inc., receives FDA Approval for its automated PROCLEIX® TIGRIS® System to Test Donated Blood with the PROCLEIX ULTRIO® Assay
The RND Group is selected by GeneNews to design, implement, and test the software for the GeneNews ColonSentry™ Product
RND Group Selected by Voyant Solutions to Develop Facility Process Automation System (FPAS™)
RND Group to Exhibit at the American Association for Clinical Chemistry (AACC) Annual Meeting
RND Group Names Tom Gardner as Vice President of Business Development
The RND Group, Inc. is named an Indiana Growth 100 Awardee
The RND Group’s client, Gen-Probe Inc., receives FDA approval for STD testing on the TIGRIS® DTS™ SYSTEM, the first fully automated, amplified molecular diagnostic testing instrument. |
